CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – VUNO, one of Korea’s leading players in the AI-backed medical device industry, anticipates breaking even in the third quarter of 2024 with a significant revenue surge attributed to its cardiac arrest prediction device, its CEO said. Th
GSK Korea said it conducted an internal campaign on Wednesday to improve awareness of human immunodeficiency virus (HIV) diseases in line with the upcoming "World AIDS (acquired immune deficiency syndrome) Day" on Dec. 1.World AIDS Day was established in January 1988 at the World Health Ministers' M
As the healthcare terrain undergoes dynamic shifts, Roche Diagnostics stays ahead in innovation, consistently adjusting to the ever-changing demands of the industry.Matthias Essenpreis, Chief Technology Officer (CTO) of Roche Diagnostics, highlighted the critical role of collaboration in driving inn
In the dynamic realm of pharmaceutical advancements, Merck has established itself as a global leader in infertility treatment, consistently setting new benchmarks through innovative therapies and groundbreaking research.Over recent years, Merck's commitment to addressing infertility has transformed
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – At the recent Radiological Society of North America (RSNA) 2023 conference, Lee Sang-hyup, Vice President of the Medical Directives Department at Lunit, engaged in an insightful discussion with Korea Biomedical Review, offering a detai
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – After navigating a tumultuous period marked by supply chain complications and an expansive global recall of its respiratory devices in 2022, Philips has shown signs of a robust recovery in the latter half of 2023.The Dutch multinationa
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – Artificial intelligence (AI) has emerged as the centerpiece of the Radiological Society of North America (RSNA) 2023 conference, cementing its position in the new era of medical imaging.The world's largest radiological conference, RSNA
The Ministry of Food and Drug Safety (MFDS) said it has appealed against the first-instance court decision that canceled the sales suspension of Meditoxin, Medytox's botulinum toxin (BTX) product.The MFDS decided to appeal under the direction of the Ministry of Justice, believing that further respon
Bukwang Pharmaceutical said that the Ministry of Food and Drug Safety has approved Latuda Tab. (ingredient: Lurasidone Hydrochloride), a treatment for schizophrenia and major depressive episodes associated with bipolar I disorder developed by Japan's Sumitomo Pharma.Latuda acts as an antagonist by b
Following AbbVie's autoimmune disease treatment, Humira (ingredient: adalimumab), Keytruda (ingredient: pembrolizumab), an immunotherapy drug from U.S. company MSD, also known as Merck in the U.S. and Canada, has emerged as the next crown jewel for biosimilar development.In Korea, Samsung Bioepis, C
Nutrasemantics, a subsidiary of the digital healthcare company Life Semantics, said it has officially entered the biopharmaceutical industry by acquiring Ceres F&D, a subsidiary of Alteogen.Nutrasemantics held an extraordinary board meeting on Tuesday and approved the acquisition of Ceres F&D.The co
VUNO said it has supplied two types of AI-based X-ray reading assistance solutions to five major military hospitals in Uzbekistan, including the Uzbekistan Central Military Hospital.The solutions introduced to the Uzbekistan military hospitals are VUNO Med-Extremity X-ray, an AI-based upper extremit
Korean medical artificial intelligence (AI) imaging companies, such as Lunit, VUNO, and Coreline Soft, are set to unveil their latest advancements and research in AI-powered imaging solutions during the Radiological Society of North America 2023 (RSNA 2023) conference.RSNA is the world's largest aca
Korea Pharma said it has signed a domestic sales contract with Waycen, a medical AI company, for WAYMED Endo, a software that analyzes endoscopic images in real-time to provide various information to physicians, assisting in polyp removal and diagnostic decisions.Through this contract, Korea Pharma
In a world still grappling with the profound impacts of the Covid-19 pandemic, the World Bio Summit 2023 emerged as a beacon of hope and collaboration. During the two-day event held on Monday and Tuesday, this global assembly of intellects and leaders converged with a singular objective: fortifying
In recent years, the conversation surrounding Official Development Assistance (ODA) from South Korea has gained significant momentum. As Korea positions itself as a crucial player in the international arena, its contributions to global health through ODA have become a topic of much interest.Korea's
As the second day of the World Bio Summit 2023 unfolds in Seoul, Korea, global leaders convened to address the heightened need for swift and collaborative efforts in the fight against infectious diseases.The second session, which started on Tuesday morning, focused on accelerating pandemic therapeut
In 2022, Korea founded the Global Training Hub for Biomanufacturing (GTH-B) with the support of the World Health Organization (WHO).The GTH-B's initiatives are part of a broader effort to support low- and middle-income countries (LMICs) in developing self-sustainable vaccine production capabilities
In an era where global health security transcends borders, World Bio Summit 2023 in Korea commenced its two-day meeting on Monday with the goal of bolstering global pandemic response capabilities.Hosted by the Ministry of Health and Welfare (MOHW) and the World Health Organization (WHO), the summit
Researchers at the Korea Advanced Institute of Science and Technology (KAIST), in collaboration with the Korea Basic Science Institute (KBSI), have discovered a cellular protein that accelerates the toxicity leading to Alzheimer's disease, revealing a novel pathological network associated with the d